Ahmed Elmokadem, Ph.D.

Research Scientist I

Ahmed earned his PhD in Biomedical Sciences from the University of Connecticut. His thesis work revolved around building statistical models to solve problems with super-resolution imaging. Other fields of experience include systems biology and pharmacokinetics. More recently, he focused on developing physiologically-based pharmacokinetic (PBPK) models to get a better mechanistic understanding of drugs’ pharmacokinetics.

Recent publications by this scientist

M-EASE-1: A Modelling and simulation study conducted to further characterize the efficacy of low-dose Empagliflozin as Adjunctive to inSulin thErapy (M-EASE) in Type 1 Diabetes Mellitus

June 13, 2019

Eudy-Byrne R, Elmokadem A, Riggs MM, Johnston C, Marquard J, Soleymanlou N, Nock V, Liesenfeld K. Poster presented at 2019 Population Approach Group in Europe (PAGE). Stockholm, Sweden. 13 June 2019. Abstract III-02.

Download PDF

Development of an open-source physiologically-based pharmacokinetic model to predict maternal-fetal exposures of CYP450-metabolized drugs

March 21, 2019

Elmokadem A. Poster presented at 2019 American Society for Clinical Pharmacology & Therapeutics (ASCPT). Washington DC. 14 Mar 2019.

Download PDF

A physiologically-based pharmacokinetic model for Voriconazole explores differences in pharmacokinetics between adults and children

October 8, 2018

Elmokadem A. Poster presented at 2018 American Conference on Pharmacometrics (ACoP9). San Diego, CA. 9 Oct 2018. Abstract #M-003.

Download PDF